Previous Article | Next Article ![]()
Journal of Virology, August 2004, p. 8935-8941, Vol. 78, No. 16
0022-538X/04/$08.00+0 DOI: 10.1128/JVI.78.16.8935-8941.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Nusra Sittidilokratna,2 and Peter J. Walker1
CSIRO Livestock Industries, Queensland Bioscience Precinct, St. Lucia 4067, Australia,1 CENTEX Shrimp, Faculty of Science, Mahidol University, Bangkok 10400, Thailand2
Received 18 August 2003/ Accepted 6 April 2004
|
|
|---|
|
|
|---|
The complete sequencing of the 26,235-nucleotide (nt) RNA genome of GAV has identified five genes ordered 5'-ORF1a/ORF1b-ORF2-ORF3-ORF4-(A)n-3' (5, 7). YHV also has a long (>22-kb) (plus-strand) single-stranded RNA genome (24, 36, 43), but sequences have been reported only for the region from the ORF1b gene to the 3' poly(A) tail (16, 28, 29). In GAV, ORF1a contains a 3C-like proteinase with VxHE
(L,V) cleavage site specificity (44); ORF1b contains SDD-type polymerase, zinc finger, and helicase motifs; and the polyprotein pp1ab is C terminally extended from pp1a by 1 ribosomal frameshifting at an AAAUUUU slippage site preceding an RNA pseudoknot (7). GAV transcribes two 3'-coterminal subgenomic mRNAs (sgmRNAs) with 5' AC termini that map to sites within conserved intergenic sequences upstream of ORF2 and ORF3 (9). Unlike coronaviruses (27) and arteriviruses (37), but as identified in the shorter three of the four sgmRNAs of the Berne equine torovirus (31, 38), the two GAV sgmRNAs do not contain 5' genomic leader sequences.
Purified YHV virions contain three structural proteins, gp116 (110 to 135 kDa), gp64 (63 to 67 kDa), and p20 (20 to 22 kDa) (16, 24, 40). The gp116 and gp64 glycoproteins are likely to form the envelope projections (32) and are generated by posttranslational cleavage of the ORF3 polyprotein (5, 16). Here we report evidence that the highly charged 144-amino-acid (aa) protein encoded by the GAV ORF2 gene is equivalent to YHV p20 and is the viral nucleocapsid (N) protein.
A 4.3-kb region downstream of the GAV ORF1b gene was amplified from LO total RNA by reverse transcription-PCR (7, 8) using the Expand Long Template PCR system (Roche), a primer targeting a terminal ORF1b region (GAV18, 5'-GGTGAGTGCCCATTCATTCCACA-3'), and an antisense primer (GAV20, 5'-TTGCCTGACAAGATGGTGAAGCC-3') targeted elsewhere that primed at a sequence in ORF3. The 4.3-kb region of DNA was purified using a QIAquick column (QIAGEN) and cloned into pGEM-T (Promega) (26), and three clones (pP18/20-1, pP18/20-9, and pP18/20-16) were sequenced in both directions using the Big-Dye dye terminator system (ABI).
The ORF2 coding sequence was amplified from clone pP18/20-16 by PCR using the primers GAV117 (5'-GCCTAGGATCCTGCAATGAACCGCCGCGCA-3') and GAV116 (5'-AATTGGATCCTTAGGGTTGAGTGTCACCTTC-3') and cloned into pQE10 (QIAGEN) or was amplified using the primers GAV173 (5'-GACGGATCCATGAACCGCCGCGCACGCC-3') and GAV116 and cloned into pGEX-KG (13). Two portions of the ORF2 coding sequence N-terminally truncated to internal in-frame Met (i.e., M11 or M61) codons (Fig. 1) were amplified using the PCR primer GAV193 (5'-CTAAGGATCCCATGCCCGTCCGGCGCCCT-3') or GAV194 (5'-TCACGGATCCTATGCAAGCATCACCATTCATT-3) in combination with GAV116 and cloned into pQE10. Primer BamHI cloning sites are underlined, and Met or termination codons are in bold. Plasmids were transformed into Escherichia coli DH5-
cells (26), clone insert orientations were determined by directional PCR, and four clones of each construct were sequenced to confirm the insert integrity.
![]() View larger version (30K): [in a new window] |
FIG. 1. Nucleotide and predicted amino acid sequences of the GAV ORF2 gene and genome regions extending into the upstream ORF1a-ORF1b and downstream ORF3 genes. The sequence is the consensus of three clones, pP18/20-1, pP18/20-9, and pP18/20-16. Indicated are the 5'-terminal positions of the 3'-coterminal sgmRNAs (arrows), the ORFa/1b and ORF2 gene termination codons (*), the in-frame AUG codons (underlined) and basic amino acids (bold) in ORFZ, and the sequence of the synthetic peptide PN1 (shaded).
|
The C-terminal ORF2 peptide PN1 (CT97YLNPNDPILPKRSTQKTI115) (Fig. 1) was synthesized by Chiron Technologies, Melbourne, Australia. An N-terminal Cys residue facilitated its covalent linkage to keyhole limpet hemocyanin (KLH) that had been activated with m-maleimidobenzoy-N-hydroxysuccinate ester (Pierce) (14).
Antiserum was produced in crossbred rabbits injected intramuscularly (two sites; 0.5 ml/site;
0.5 mg of KLH-PN1/site or
0.2 mg of GST-ORF2/site) with GST-ORF2 inclusion bodies or KLH-PN1 peptide emulsified in an equal volume of Montanide ISA70 adjuvant (Seppic, Paris, France). The rabbits were given a booster injection twice at intervals of 2 to 3 weeks, and the specificity and titer of the peptide antiserum were assessed by an enzyme-linked immunosorbent assay (14).
Proteins separated by SDS-PAGE (26) were either stained with 0.2% Coomassie blue R250 or transferred semidry onto Hybond C (Amersham) membranes (14). Western blotting was performed using a 1:200 dilution of rabbit antibody in 5% skim milk powder, and detection was carried out using a 1:1,000 dilution of biotinylated donkey anti-rabbit immunoglobulin (Amersham), a 1:1,000 dilution of streptavidin-biotin-horseradish peroxidase conjugate (Amersham), and 4-chloro-1-naphthol (14).
Small pieces (<1 mm2 in diameter) of LO tissue were fixed in 4% paraformaldehyde-0.1% glutaraldehyde in 66 mM cacodylate buffer (pH 7.4) for 48 h at 4°C, cryopreserved in polyvinylpyrrolidone-sucrose, snap-frozen in liquid nitrogen, and cryosubstituted with methanol containing 0.5% uranyl acetate for 48 h at 85°C. The tissue was warmed to 45°C, embedded in Lowicryl K11 M, and UV polymerized. Ultrathin sections mounted on carbon- and Formvar-coated nickel grids were incubated in a 1:20 dilution of KLH-PN1 or GST-ORF2 antiserum in phosphate-buffered saline (PBS) block solution (PBS, 0.2% bovine serum albumin, 0.2% fish skin gelatin, 20 mM glycine, 0.05% Tween 20) for 2 h. Control sections were incubated in prebleed serum. After being washed in PBS block solution, the sections were incubated for 1 h in goat anti-rabbit immunoglobulin G conjugated with 10-nm-diameter colloidal gold particles (BioCell) diluted 1:40 in PBS block solution and washed twice for 5 min in water. The tissues were stained with 4% uranyl acetate and then with Reynold's lead citrate and examined at 80 kV with a Jeol 1010 transmission electron microscope.
The 435-nt ORF2 gene of GAV encodes a 144-aa polypeptide and is bounded by intergenic sequences of 93 nt to the upstream ORF1a-ORF1b gene and 57 nt to the downstream ORF3 gene (Fig. 1). The ORF2 protein has a deduced molecular mass of 15,998 Da and a pI of 9.75 and is highly hydrophilic, containing 20 basic (14%) and 13 acidic (9%) residues. There is a cluster of 7 arginines in the N-terminal 26 aa, and 5 of the 8 C-terminal residues are acidic. ORF2 also contains no cysteines and 19 prolines (13%), 8 of which are clustered between residues 7 and 22.
BLAST 2.0 (1) searches of the GenPept or translated sequences of the GenBank database identified no polypeptides significantly related to ORF2. This is consistent with alignments of pp1ab motifs showing that GAV is evolutionarily very distant from the vertebrate nidoviruses (7). In size, the 144-aa ORF2 is between the N proteins of arteriviruses (110 to 128 aa) (4, 10, 12, 23) and toroviruses (160 to 167 aa) (11, 18, 30) and significantly smaller than the 377- to 454-aa N proteins of coronaviruses (19). ORF2 displays general structural similarities to torovirus N proteins in the absence of cysteines and a high prevalence of prolines and of basic residues that are likely to facilitate nucleic acid binding (15). It is also noteworthy that the architecture of the helical nucleocapsids and rod-shaped virions of GAV (33, 34) and YHV (2, 3, 24, 40, 43) somewhat resemble torovirus nucleocapsid and virion structures (41, 42). Moreover, curled virions similar in form to the crescent-shaped torovirus particles (42) have been observed in purified YHV (24), suggesting that okavirus nucleocapsids are also quite flexible. As N proteins play a significant role in defining the structures of nucleocapsids and virions, it is not surprising that the GAV N protein might share more general similarities with the cognate proteins of toroviruses than with those of coronaviruses or arteriviruses, which have distinctly different virion architectures.
Western blotting with antiserum to either the KLH-PN1 peptide or the GST-ORF2 fusion protein detected the ORF2 gene product (molecular mass,
22 kDa) in the LO and gill tissue of a single moribund P. monodon prawn sampled at 6 days after injection (34) with GAV (Fig. 2). In LO, three smaller polypeptides (molecular masses,
21, 20, and 17 kDa) were also detected, although the 17-kDa protein was detected weakly by the GST-ORF2 antiserum (Fig. 2a). Since these initial ORF2 size estimates were based on poorly resolved, prestained protein standards, they were reassessed using biotinylated protein standards. In Western blots with the PN1 peptide antiserum (Fig. 2c and 3a), the native ORF2 protein migrated alongside the 20-kDa biotinylated standard, and the relative migration of the His6-ORF2 protein (molecular mass,
21.5 kDa) was consistent with the calculated additional mass (1,639 Da) of its N-terminal His6 tag. The estimated size of ORF2 was thus revised to 20 kDa, and the sizes of the three smaller ORF2 derivatives were revised to 19, 17, and 14.5 kDa, respectively.
![]() View larger version (36K): [in a new window] |
FIG. 2. Western blot of uninfected and GAV-infected P. monodon tissues carried out with antiserum to E. coli-expressed GST-ORF2 fusion protein (a) and KLH-linked peptide PN1 (b and c). (a and b) LO (lanes 1 and 2) and gill tissues (lanes 3 and 4) from an uninfected prawn (lanes 1 and 3) and a GAV-infected prawn (lanes 2 and 4). Three proteins smaller than the ORF2 protein detected in LO tissue are indicated ( ). (c) GAV-infected gill tissue (lane 1) and the E. coli-expressed His6-ORF2 fusion protein (lane 2). Proteins were separated by SDS-PAGE in 12% (a and b) or 15% (c) polyacrylamide gels. The molecular masses (in kilodaltons) of prestained protein standards (Bio-Rad) (a and b) and biotinylated protein standards (Amersham) (c) are indicated (lanes M).
|
![]() View larger version (30K): [in a new window] |
FIG. 3. Western blot of native ORF2 in GAV-infected LO and gill tissues compared to His6-ORF2 and N-terminally truncated His6-ORF2 fusion proteins expressed in E. coli. (a) GAV-infected gill tissue (lane 1) and LO tissue (lane 6) and IPTG-induced E. coli cultures transformed with pQE-ORF2 (lane 2), pQE-ORF2-M11 (lane 3), pQE-ORF2-M61 (lane 4), and pQE10 (lane 5) were resolved in a 15% polyacrylamide gel and immunodetected with KLH-PN1 peptide antiserum. Lane M contains biotinylated protein standards. (b and c) GAV-infected gill (lane 1) and IPTG-induced E. coli cultures transformed with pQE-ORF2 (lane 2), pQE10 (lane 3), pQE-ORF2-M11 (lane 4), and pQE-ORF2-M61 (lane 5) resolved in a 12% polyacrylamide gel and immunodetected using antiserum to GST-ORF2 (b) or KLH-PN1 peptide (c). Lanes M contain BenchMark prestained protein ladders (Invitrogen). The predominant His6-ORF2 fusion proteins ( ) and minor larger and smaller His6-ORF2 fusion protein forms that were also immunodetected ( ) are indicated.
|
Two smaller forms of the Berne torovirus nucleocapsid (N) protein have been detected in infected cells, although there are conflicting reports about whether these result from proteolysis (15) or internal initiation of translation (30). To establish whether the 14.5-kDa ORF2 derivative detected in LO tissue might be due to internal initiation of translation, His6-ORF2 proteins N-terminally truncated upstream of Met11 and Met61 were expressed in E. coli and analyzed in Western blots. The PN1 peptide antiserum detected the His6-ORF2 (
21.5-kDa), His6-ORF2-M11 (
19-kDa), and His6-ORF2-M61 (
15-kDa) proteins in addition to three minor polypeptides that were proportionally larger and smaller than each primary recombinant protein (Fig. 3a and c). Although bacterial proteins were also obvious, all but the smallest minor His6-ORF2-related polypeptides were also detected by the GST-ORF2 antiserum (Fig. 3b). Although the 15-kDa His6-ORF2-M61 protein was similar in size to the 14.5-kDa ORF2 derivative detected in LO tissue (Fig. 2), importantly, unlike the latter, it reacted well with the GST-ORF2 antiserum (compare Fig. 2a and 3b).
We hypothesize, therefore, that the 14.5-kDa ORF2 derivative is more likely the result of proteolysis at a C-terminal position in or beyond the PN1 peptide sequence. However, to be consistent with our data, antibodies to GST-ORF2 would primarily have to target epitopes C terminal to the proteolysis site. In support of this supposition, a protein proportionally smaller than each His6-ORF2 fusion protein, suggesting that it was trimmed at a common C-terminal position, was detected by antiserum to the PN1 peptide but not to GST-ORF2 (Fig. 3b and c). Although the overall homology was poor, a Clustal W multiple sequence alignment (data not shown) identified a trypsin cleavage motif (KR109) in the GAV ORF2 sequence encompassed by the PN1 peptide that was also present at a comparable position in torovirus N proteins (11, 18, 30). Mutagenesis studies will be required to determine the relevance of this or other potential proteolysis sites in the C-terminal regions of these proteins.
It is of note that the LO tissue used in this analysis was from a moribund prawn acutely infected with GAV and nearing death. Although this fact ensured the presence of high virus protein levels, significant LO structural and cellular degeneration occurs late in infection (34). This degeneration likely involves apoptotic cell death, as has been reported with YHV (17), and explains why ORF2 may have been subjected to proteolysis. Late in infection, nucleocapsids and virions appear in high numbers in gill cells, usually in the absence of major cytopathology, and large arrays of GAV particles accumulate at the external boundaries of epidermal cells and the gill cuticles (34), presumably to be eliminated following molting (21). This accumulation of mature virions likely explains why only intact ORF2 was detected in the gill tissues of the same prawn.
YHV purified from the hemolymph of infected P. monodon prawns by Urografin (Schering) density gradient centrifugation (43) was analyzed by SDS-PAGE and Western blotting to verify that antiserum to the GAV ORF2 gene product would cross-detect the nonglycosylated YHV p20 protein. The three YHV structural proteins (gp116, gp64, and p20) were detected by Coomassie blue staining (Fig. 4a), and the p20 protein, which appeared to be slightly larger than the GAV ORF2 protein synthesized in gill tissue, cross-reacted with the GST-ORF2 antiserum (Fig. 4b).
![]() View larger version (40K): [in a new window] |
FIG. 4. (a) Structural proteins (gp116, gp64, and p20) of purified YHV (lane 1) detected by staining with Coomassie blue. (b) Western blot of purified YHV (lane 1) and GAV-infected gill tissues (lane 2) with GAV GST-ORF2 antiserum. Proteins were resolved in a 12% polyacrylamide gel. Lanes M contain protein standards (a) and biotinylated protein standards (Amersham) (b), with molecular masses (in kilodaltons) indicated.
|
16-nm-diameter) tubular GAV nucleocapsids within the cell cytoplasm and were often observed at the nucleocapsid ends rather than at positions on their longitudinal surfaces (Fig. 5b). Gold particles also associated with nucleocapsids within mature rod-shaped, enveloped GAV virions (Fig. 5d) and within newly formed virions that had not completely disaggregated into discrete rod-shaped structures and that occurred where nucleocapsids appeared to be actively budding or had recently budded into membranous endoplasmic vesicles (Fig. 5e). Within virions, gold particles were also commonly associated with nucleocapsid ends or with positions where nucleocapsids appeared to have been cross-sectioned transversely. Gold particles were not seen to associate with any specific cellular structures in cytoplasmic regions where GAV nucleocapsids were not evident. Similar results were obtained with the GST-ORF2 antiserum (data not shown), and no association of gold particles with GAV nucleocapsids was observed with preimmune serum (Fig. 5c).
![]() View larger version (135K): [in a new window] |
FIG. 5. Immunoelectron microscopy of ultrathin sections of GAV-infected LO cells using prebleed (c) or KLH-PN1 peptide (a, b, d, and e) antiserum. No gold particles (10 nm in diameter) associated with GAV nucleocapsids with prebleed sera. With the PN1 peptide antiserum, gold particles associated with free striated nucleocapsids (a and b) and nucleocapsids within mature rod-shaped virions (d) and newly formed virions (e) that were observed budding into a membranous endoplasmic vesicle. Good examples of gold particles bound to nucleocapsid ends or to areas where the nucleocapsids had been cross-sectioned laterally are highlighted (arrowheads). Bars represent 100 nm.
|
Immuno-gold particle labeling of GAV nucleocapsids by antibodies to the ORF2 synthetic peptide and recombinant GST-ORF2 fusion protein offers strong evidence that the 20-kDa ORF2 gene product is the viral N protein. YHV contains a homolog of the GAV ORF2 gene (28, 29), and it is clear from data presented here that the ORF2 protein is equivalent to the nonglycosylated p20 structural protein of YHV (16). Moreover, a monoclonal antibody reactive for the YHV p20 protein has also recently been shown to bind to nucleocapsids (32). The finding that the ORF2 gene encodes the GAV N protein conspicuously distinguishes this crustacean okavirus from the vertebrate nidoviruses in which the N protein gene resides in the 3'-terminal genome region downstream of genes coding for the virion glycoproteins and membrane protein.
Present address: Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892-0720. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»